首頁 > 市場調查報告書 > 醫療設備

透析設備

市場調查報告書

商品編碼

1918132

血液透析及腹膜透析市場－2026-2031年預測

Hemodialysis and Peritoneal Dialysis Market - Forecast from 2026 to 2031

出版日期: 2026年01月15日 | 出版商:

Knowledge Sourcing Intelligence | 英文 152 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

預計血液透析和腹膜透析市場將從 2025 年的 1,205.45 億美元成長到 2031 年的 1,767.49 億美元，複合年成長率為 6.59%。

由於腎臟疾病的增加、技術的進步以及醫療服務模式的變革，血液透析和腹膜透析市場正在快速擴張。當腎臟無法清除血液中的毒素時，就需要進行透析治療。透析包括血液透析和腹膜透析。血液透析是一種常見的血液淨化方法，患者每週需在透析中心透過手臂進行三到五次透析；腹膜透析則是一種持續的居家透析方法，患者每天透過腹部進行腹膜腔的清潔。慢性疾病的流行、生活方式因素和技術創新之間的協同作用正在推動市場成長。

主要市場促進因素

腎臟疾病負擔與風險因素

腎臟疾病的激增以及人們日益成長的擔憂正在推動該行業的成長，因為腎移植需要進行大規模手術、與捐贈者進行配型，並且需要終身服用免疫抑制劑以防止器官排斥。慢性病和文明病（包括肥胖、糖尿病和高血壓）的發病率上升也進一步推動了全球市場的擴張。

截至2021年，糖尿病成人患者人數最多的地區是西太平洋地區（1.67億）、南亞地區（8,800萬）和歐洲（5,900萬）。隨著糖尿病發生率的上升，末期腎功能衰竭（ESRD）病例也增加。此外，營養不良、不健康的生活方式和缺乏運動也是導致腎臟疾病的因素。 60%的健康問題都與生活方式因素有關，包括營養不良、吸煙、飲食不當、藥物濫用、壓力和飲酒。由於這些因素，全球範圍內的ESRD病例都在增加，從而對透析解決方案產生了持續的需求。

消費品市場趨勢

在整個預測期內，各國政府預計將在病人安全、以病人為中心的照護和改善治療效果方面投入大量資金。企業正在生產由複合材料製成的導管，這些材料能夠耐受過氧化物、碘和酒精等化學物質的侵蝕。透析器的新製造技術（改善表面接觸和截留膜性能以提高擴散效率）正在積極推動耗材的擴張，進而促進血液透析和腹膜透析市場的成長。耗材市場涵蓋血管、濃縮液、導管及相關產品，為製造商提供了重要的經常性商機。

住院透析的優勢

由於醫院擁有大量訓練有素、經驗豐富的醫護人員，院內透析的優勢預計在未來幾年內仍將保持強勁。透析中心和醫院等醫療機構中合格且技術精湛的腎臟護理團隊能夠確保最佳治療效果並改善透析結果。多種因素預計將推動市場成長，包括競爭對手專注於建立獨立的透析中心以及患者對院內透析的接受度不斷提高。各公司正致力於開發具有多種介入功能的客製化血液透析機，以滿足特定患者群體和臨床場景的需求。

技術進步

影響市場成長的關鍵因素包括透析機技術的進步以及公眾對透析治療益處的日益了解。便攜性、易用性和可靠性等性能提升的血液透析機需求旺盛。居家血液透析技術的廣泛應用提高了患者滿意度，並賦予患者更大的獨立性。腹膜透析因其經濟實惠且無需專用設備即可在家中進行，正日益受到患者的青睞。此外，自動化腹膜透析機的廣泛應用有望推動市場成長，因為它能夠實現夜間治療，最大限度地減少對日常生活的干擾。

法規環境

全球政府監管力度的加強正透過統一的品質標準推動市場成長。血液透析和腹膜透析服務提供者必須遵守美國醫療保險和醫療補助服務中心 (CMS) 制定的品質標準。美國食品藥物管理局(FDA) 對醫療設備的品質、安全性、有效性和標籤制定了相關要求。在歐盟銷售的醫療設備必須通過多項測試，以確保其符合歐盟醫療設備指令的品質和安全要求。在日本，醫療器材必須符合厚生勞動省的法規。中國已頒布一部符合國際和國內標準的醫療設備法，並在主要市場建立了統一的品質標準。

區域趨勢

在北美市場主導地位

北美血液透析和腹膜透析市場正蓬勃發展，這得益於知名製造商的存在、政府對先進醫療設備研發的大量投入以及完善的報銷體系。隨著腎衰竭和慢性腎臟病的日益增多，透析的普及率也不斷提高。醫療保健成本的上漲、政府的扶持政策以及居民可支配收入的增加，都進一步推動了該市場的發展。

亞太地區的成長軌跡

預計亞太地區在預測期內將佔據顯著的市場佔有率。先進產品的不斷發展、老齡化人口的不斷擴大以及腎衰竭發病率的上升預計將推動市場成長。根據國際糖尿病聯盟（IDF）估計，東南亞已有8,800萬人患有慢性腎臟病，預計到2045年這數字將達到1.53億人。政府主導的增加、慢性腎臟病（CKD）意識提升計畫的發展、技術先進的產品以及新建的現代化醫療設施都在影響市場成長。

血液透析和腹膜透析市場在技術進步、慢性病負擔加重以及醫療服務可近性提高的推動下不斷發展。

本報告的主要優勢：

深入分析：取得以客戶群、政府政策和社會經濟因素、消費者偏好、垂直產業和其他細分市場為重點的深入市場洞察，涵蓋主要地區和新興地區。
競爭格局：了解主要企業採取的策略舉措，並了解透過正確的策略實現市場滲透的潛力。
市場促進因素與未來趨勢：探索動態因素和關鍵市場趨勢，以及它們將如何塑造未來的市場發展。
可執行的建議：利用洞察力為策略決策提供訊息，從而在動態環境中開拓新的業務管道和收入來源。
受眾範圍廣：對新興企業、研究機構、顧問公司、中小企業和大型企業都有益處且經濟高效。

它是用來做什麼的？

產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範及其影響、新產品開發、競爭影響

分析範圍

歷史資料（2021-2025 年）和預測資料（2026-2031 年）
成長機會、挑戰、供應鏈前景、法規結構、客戶行為和趨勢分析
競爭對手定位、策略和市場佔有率分析
按業務板塊和地區（國家）分類的收入成長和預測分析
公司概況（策略、產品、財務資訊、關鍵趨勢等）

The hemodialysis and peritoneal dialysis market is expanding rapidly driven by rising kidney-related illnesses, technological advancements, and evolving healthcare delivery models. Dialysis procedures-performed when kidneys cannot remove toxins from blood-encompass hemodialysis, a common blood cleaning procedure conducted at dialysis centers three to five times weekly through arm access, and peritoneal dialysis, a continuous home-based procedure that cleans the peritoneal cavity in the abdomen daily through abdominal access. The convergence of chronic disease prevalence, lifestyle factors, and technological innovation is propelling market growth.

Primary Market Drivers

Kidney Disease Burden and Risk Factors

Industry growth is attributed to surging kidney-related illnesses and concerns, as kidney transplantation requires major procedures, donor matching, and lifetime immunosuppressant medication regimens to prevent organ rejection. The rising incidence of chronic diseases and lifestyle-related illnesses including obesity, diabetes, and hypertension further supports worldwide market expansion.

In 2021, adults living with diabetes were most prevalent in the Western Pacific (167 million), South Asia (88 million), and Europe (59 million). End-stage renal disease cases are rising in correlation with increasing diabetes incidence. Additionally, kidney problems result from poor nutrition, unhealthy lifestyles, and lack of physical activity. Lifestyle factors are responsible for 60% of health-related issues, including malnutrition, smoking, improper diet, drug misuse, stress, and alcohol consumption. These variables are causing ESRD instances to increase internationally, creating sustained demand for dialysis solutions.

Consumables Market Evolution

Throughout the projection period, governments are anticipated to make substantial expenditures improving patient safety, patient-centered treatment, and efficacy. Companies are producing catheters composed of complex materials impervious to chemicals like peroxides, iodine, and alcohol. New production techniques for dialyzers-featuring better surface contact and cutoff membrane properties for higher diffusion-positively affect consumables expansion, driving hemodialysis and peritoneal dialysis market growth. The consumables market encompasses bloodlines, concentrates, catheters, and related items, representing significant recurring revenue opportunities for manufacturers.

Hospital-Based Dialysis Dominance

Hospital-based dialysis dominance is projected to remain strong in upcoming years due to substantial availability of highly trained, experienced healthcare workers in hospital settings. In healthcare environments like dialysis centers and hospitals, qualified and skilled renal care teams guarantee optimal care and improved dialysis outcomes. Various factors-including competitors' increased focus on creating independent dialysis facilities and patients' growing acceptance of in-center dialysis-are projected to drive market growth. Companies are focusing on developing customized hemodialysis equipment with diverse interventions, addressing specific patient population needs and clinical scenarios.

Technological Advancement

Major factors influencing market growth include technological advancements in dialysis equipment and growing public awareness of treatment benefits. Hemodialysis machines with improved characteristics including portability, usability, and dependability are experiencing high demand. Hemodialysis technology availability for home use has increased patient satisfaction and offered greater independence. Peritoneal dialysis is gaining popularity as a cost-effective and practical alternative for patients, capable of being performed at home without specialized equipment. Additionally, automated peritoneal dialysis equipment availability is likely to fuel market growth, enabling overnight treatments that minimize lifestyle disruption.

Regulatory Environment

Government regulations have been increasing globally, fueling market growth through quality standardization. Hemodialysis and peritoneal dialysis service providers must adhere to quality standards set by the Centres for Medicare & Medicaid Services. The FDA establishes requirements for medical devices regarding quality, safety, efficacy, and labeling. Before marketing in the European Union, medical devices must pass multiple tests guaranteeing quality and safety under the EU Medical Device Directive. In Japan, equipment must adhere to Ministry of Health, Labour, and Welfare regulations. China has enacted medical device laws following international and domestic standards, creating harmonized quality expectations across major markets.

Regional Dynamics

North American Market Leadership

The North American hemodialysis and peritoneal dialysis market is growing due to well-known manufacturers' presence, major government expenditures in cutting-edge medical device development, and supportive reimbursement frameworks. Dialysis prevalence is rising due to increasing kidney failures and Chronic Kidney Disease. Increasing healthcare spending, government initiatives, and high disposable income further promote market development.

Asia Pacific Growth Trajectory

The Asia Pacific region is anticipated to hold significant market share during the projected period. Increased development of cutting-edge products, expanding elderly populations, and rising renal failure occurrences are predicted to promote market growth. The IDF estimates 88 million individuals in Southeast Asia already have diabetes, with 153 million likely to have the disease by 2045. Increased government initiatives, CKD awareness programs, technologically advanced products, and recently built state-of-the-art healthcare facilities are influencing market growth.

Recent Developments

In April 2023, AWAK Technologies and Singapore General Hospital initiated a pre-pivotal clinical investigation of a wearable peritoneal dialysis device. Also in April 2023, Tablo received FDA approval for usage in various locations including home and hospital settings, featuring user-friendly interactive touchscreens with 3-D graphics and conversational instructions. In February 2023, the first central government building for hemodialysis was fitted with online hemodiafiltration machines and inaugurated at Safdarjung Hospital in New Delhi, India.

The hemodialysis and peritoneal dialysis market continues evolving, driven by technological sophistication, chronic disease burden, and healthcare accessibility improvements.

Key Benefits of this Report:

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data from 2021 to 2025 & forecast data from 2026 to 2031
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.)

Hemodialysis and Peritoneal Dialysis Market Segmentation

By Type
Hemodialysis
Peritoneal dialysis
By Product
Device
Consumables
By End-User
Home-based
Hospital-based
By Geography
North America
United States
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
France
United Kingdom
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Others
Asia Pacific
China
India
Japan
South Korea
Indonesia
Thailand
Others

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET BY TYPE

5.1. Introduction
5.2. Hemodialysis
5.3. Peritoneal dialysis

6. HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET BY PRODUCT

6.1. Introduction
6.2. Device
6.3. Consumables

7. HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET BY END-USER

7.1. Introduction
7.2. Home-based
7.3. Hospital-based

8. HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET BY GEOGRAPHY

8.1. Introduction
8.2. North America
- 8.2.1. USA
- 8.2.2. Canada
- 8.2.3. Mexico
8.3. South America
- 8.3.1. Brazil
- 8.3.2. Argentina
- 8.3.3. Others
8.4. Europe
- 8.4.1. Germany
- 8.4.2. France
- 8.4.3. United Kingdom
- 8.4.4. Spain
- 8.4.5. Others
8.5. Middle East and Africa
- 8.5.1. Saudi Arabia
- 8.5.2. UAE
- 8.5.3. Others
8.6. Asia Pacific
- 8.6.1. China
- 8.6.2. India
- 8.6.3. Japan
- 8.6.4. South Korea
- 8.6.5. Indonesia
- 8.6.6. Thailand
- 8.6.7. Others